Safetek International, Inc.

Safetek International, Inc., through its subsidiaries, manufactures and distributes organic green cleaning products for families, pets, and employees in the United States. The company's offers household products, such as laundry detergents, cleaners, diapers, etc.; and personal care items that comprise hair care products, cosmetics, and toothpastes. It also provides Bio+Green Crystals that are nutraceutical, hypoallergenic, and cleaning products for people suffering from allergies, sensitive skin, asthma, and other respiratory conditions; BioDfence, a range of formulated topical skin protectant products for athletes; Handsan that is a nutraceutical sanitizer product for children and pets; eco-friendly cleaners that reduces carbon footprint in the supply chain; and EcoSafe cleaning and non-PVC food film products. Safetek International, Inc. is based in Boca Raton, Florida.

Safetek International, Inc. trades as SFIN on OTC. The company is classified in Financial Services / Shell Companies and reports in USD.

The current profile places the business in Shell Companies. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $0 of revenue and -$2.93M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Safetek International, Inc. can be compared against peers such as Active Health Foods, Inc., Ecomax, Inc., Frontera Investment, Inc., Global Brokerage, Inc., Qiansui International Group Co. Ltd., S A M Trade Asia Pte Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $321, beta of -1.71, and return on equity of +94.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SFIN currently shows total debt of $76,558 and beta of -1.71. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.SafetekInternational.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.